Mega-ROX Trial

All Done!

A bit more to do?    Log in


A neonatal trial that spans hospital and intensive care

One of the trials currently preparing to go live at Spiral is PLATIPUS, an Australasian platform trial led out of the University of Melbourne, focused on improving outcomes for babies born prematurely.

Access this article in our blog »

Platipus clinical trial. Spiral Software.



 

About the Mega-ROX Trial

Mega-ROX is multiple parallel multi-centre, randomised, single blinded clinical trials comparing conservative vs. liberal oxygenation targets in mechanically ventilated adults in the intensive care unit nested within a single 40,000 patient mega trial. The primary outcome is in-hospital all-cause mortality up to 90 days from the date of randomisation.

About the software

This is Spinnaker, a user friendly, bespoke application platform that helps researchers find answers to important medical questions. The team behind the platform can adapt the software to match your study and we are especially interested in doing this for novel trials.

Spinnaker is a cloud based, integrated software/database solution for randomising patients using any design methodology including response adaptive methods; backed up by an electronic data capture application that is intuitive and particular. The application also includes management functions to alert relevant people about events (e.g. SAE), to manage drug inventory and to report on progress.

You can read more on the Spiral website https://spiral.co.nz or contact Audrey on [email protected]

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.

Made with love in New Zealand.